These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23493590)

  • 21. New aspects of injectable contraception.
    Phillips OP
    Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability.
    Prabhakaran S; Sweet A
    Contraception; 2012 May; 85(5):453-7. PubMed ID: 22079605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic intracranial hypertension associated with depot medroxyprogesterone.
    Chan JW
    Eye (Lond); 2006 Dec; 20(12):1396-7. PubMed ID: 16440012
    [No Abstract]   [Full Text] [Related]  

  • 24. Counseling teens and young women on Depo-Provera.
    Tonelli M; Nicoletti A
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):297-8. PubMed ID: 16171737
    [No Abstract]   [Full Text] [Related]  

  • 25. Injectable contraceptives: a worldwide perspective.
    Affandi B
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):3-4. PubMed ID: 16259804
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute necrotic skin reaction to intramuscular Depo-Provera.
    Clark SM; Lanigan SW
    Br J Dermatol; 2000 Dec; 143(6):1356-7. PubMed ID: 11122072
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'.
    Lanza LL; McQuay LJ; Rothman KJ; Bone HG; Kaunitz AM; Harel Z; Ataher Q; Ross D; Arena PL; Wolter KD
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):306. PubMed ID: 24062508
    [No Abstract]   [Full Text] [Related]  

  • 28. Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.
    Kaunitz AM
    Arch Gynecol Obstet; 2001 Aug; 265(3):119-23. PubMed ID: 11561738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Black box' warning added to contraceptive injection.
    FDA Consum; 2005; 39(2):3. PubMed ID: 16124078
    [No Abstract]   [Full Text] [Related]  

  • 30. The members' enquiry service: frequently asked questions.
    de Souza A; Brechin S; Penney G;
    J Fam Plann Reprod Health Care; 2004 Jan; 30(1):57-8. PubMed ID: 15006318
    [No Abstract]   [Full Text] [Related]  

  • 31. Depot medroxyprogesterone acetate in teens: A risk for bone health?
    Bachrach LK; Cundy T; Ott SM
    Pediatrics; 2000 Nov; 106(5):1137-8. PubMed ID: 11061788
    [No Abstract]   [Full Text] [Related]  

  • 32. Monthly injection provides new contraceptive choice.
    FDA Consum; 2001; 35(1):5. PubMed ID: 11930928
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant: making decisions in the absence of evidence.
    Holman R; Stephen G
    J Fam Plann Reprod Health Care; 2005 Oct; 31(4):333-4. PubMed ID: 16274569
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics.
    Thurman A; Kimble T; Hall P; Schwartz JL; Archer DF
    Contraception; 2013 Jun; 87(6):738-43. PubMed ID: 23265980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 17-year-old mother seeking contraception.
    Grimes DA
    JAMA; 1996 Oct; 276(14):1163-70. PubMed ID: 8827970
    [No Abstract]   [Full Text] [Related]  

  • 37. Same-day initiation of hormonal contraceptives.
    Scott T
    Am Fam Physician; 2009 Oct; 80(7):690. PubMed ID: 19817338
    [No Abstract]   [Full Text] [Related]  

  • 38. Depot-medroxyprogesterone acetate: an update.
    Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval.
    Smit J; Botha J; McFadyen L; Beksinska M
    Contraception; 2004 Jan; 69(1):3-7. PubMed ID: 14720612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary tract infection in the users of depot-medroxyprogesterone acetate.
    Berger RE
    J Urol; 2005 Sep; 174(3):941. PubMed ID: 16093999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.